We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

87 hedge funds and large institutions have $50.7M invested in Asensus Surgical, Inc. in 2016 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

51% more call options, than puts

Call options by funds: $160K | Put options by funds: $106K

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

33% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 18

14% more funds holding

Funds holding: 7687 (+11)

20% less capital invested

Capital invested by funds: $63.8M → $50.7M (-$13.1M)

Holders
87
Holders Change
+11
Holders Change %
+14.47%
% of All Funds
2.17%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
16
Increased
24
Reduced
18
Closed
5
Calls
$160K
Puts
$106K
Net Calls
+$54K
Net Calls Change
-$144K
Name Holding Trade Value Shares
Change
Change in
Stake
AC
1
Aisling Capital
New York
$10.8M
SHI
2
SV Health Investors
Massachusetts
$9.81M
JP Morgan Chase
3
JP Morgan Chase
New York
$5.5M
SG
4
StepStone Group
California
$3.94M
Vanguard Group
5
Vanguard Group
Pennsylvania
$3.09M +$254K +12,379 +7%
BFA
6
BlackRock Fund Advisors
California
$2.92M +$461K +22,513 +15%
MCM
7
Masters Capital Management
Georgia
$2.47M -$160K -7,783 -5%
BIT
8
BlackRock Institutional Trust
California
$1.46M +$150K +7,297 +9%
AQR Capital Management
9
AQR Capital Management
Connecticut
$1.25M -$1.58M -77,176 -51%
IBT
10
International Biotechnology Trust
United Kingdom
$1.16M +$1.4M +68,391 New
State Street
11
State Street
Massachusetts
$1.1M +$167K +8,157 +14%
Northern Trust
12
Northern Trust
Illinois
$897K +$7.36K +359 +0.7%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$637K +$17.8K +868 +2%
Millennium Management
14
Millennium Management
New York
$610K +$740K +36,114 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$445K +$83.8K +4,087 +18%
BIM
16
BlackRock Investment Management
Delaware
$399K
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$352K -$266K -12,997 -38%
Morgan Stanley
18
Morgan Stanley
New York
$328K +$258K +12,573 +184%
TCIM
19
TIAA CREF Investment Management
New York
$258K +$9.33K +455 +3%
NPC
20
National Planning Corporation
California
$255K -$328 -16 -0.1%
BCM
21
Bridgeway Capital Management
Texas
$242K
California Public Employees Retirement System
22
California Public Employees Retirement System
California
$210K
CWG
23
C WorldWide Group
Denmark
$195K
Charles Schwab
24
Charles Schwab
California
$187K
California State Teachers Retirement System (CalSTRS)
25
California State Teachers Retirement System (CalSTRS)
California
$186K -$6.46K -315 -3%

ASXC Hedge Fund Activity: Q4 2016 in Review

87 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q4 2016, worth a combined $50.7M — down 20% from $63.8M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ASXC positions and 5 closed out — a net gain of 11 holders — while 24 added to existing stakes and 18 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $740K. The largest seller was AQR Capital Management, cutting an estimated $1.58M.

  • 87 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q4 2016, up from 76 in Q3 2016.
  • Funds reported $50.7M of Asensus Surgical, Inc. stock for Q4 2016, down 20% quarter-over-quarter.
  • 16 funds opened new Asensus Surgical, Inc. positions in Q4 2016 and 5 closed out, a net change of +11 holders.
  • The largest Asensus Surgical, Inc. buyer in Q4 2016 was Millennium Management, an estimated $740K added.
  • The largest Asensus Surgical, Inc. seller in Q4 2016 was AQR Capital Management, an estimated $1.58M sold.

Based on aggregated 13F filings for Q4 2016.